Comparing strategic and sponsor buyers

For owners of an OB-GYN practice, a sale is a decision about more than headline price. The buyer may change who controls staffing, how the practice relates to hospitals, where cash is invested, and how physicians share in future value. Strategic buyers and financial sponsors can both offer a credible path, but they tend to value different things and build deals differently. Understanding those mechanics helps partners compare real proceeds, continuing obligations, along with clinical and operational autonomy, and the likelihood that a transaction will close on agreed terms. The right comparison starts with the practice’s goals and constraints, then tests each offer against the same assumptions.

What the buyer intends to own

A strategic buyer is an operating organization seeking to add a practice, physicians, geography, service capacity, or referral relationships to an existing platform. It could be another physician group, a regional women’s health organization, a hospital affiliated entity, or a larger care delivery company. Its value thesis often rests on combining operations: sharing billing, recruiting, call coverage, technology, management, or contracting infrastructure. The buyer may expect the practice’s locations and clinicians to strengthen its existing network, and may have specific plans for integrating them.

A sponsor buyer is generally a private investment firm or an acquisition company backed by one. Its principal aim is to invest capital, build an organization, and realize value through growth and a later sale or other liquidity event. It may acquire a controlling stake, pair the practice with a platform group, and pursue add-on acquisitions. Sponsors vary considerably. Some have deep physician practice experience and long-standing operating teams; others rely on a platform’s leaders or newly hired management. A sponsor’s plan therefore depends on both the capital provider and the operators who will run the business.

These labels do not determine the actual deal. A strategic buyer can use an earnout and retain sellers in leadership roles. A sponsor can leave local operations largely intact while centralizing finance and human resources. A sponsor-backed platform can itself become the strategic acquirer in a later transaction. Ask each bidder to describe its ownership structure, decision makers, operating investment thesis, financing plan, and the expected role for the current partners. Request a simple organization chart showing which entity would buy the practice, employ the clinicians, hold assets, and enter service or lease agreements.

The buyer’s thesis matters because it shapes what the buyer will pay for and what it will expect after closing. A strategic buyer may value a location that fills a geographic gap or a team that supports a broader service offering. A sponsor may value repeatable earnings, stable physician leadership, and opportunities to add practices. Neither thesis is automatically better for owners. The question is whether the capabilities being purchased are actually present and whether the proposed integration can be executed without impairing the practice’s ability to recruit and serve its communities.

How to compare price with proceeds

Offers commonly quote enterprise value, which represents the value of the operating business before subtracting debt and making other closing adjustments. It is not the same as cash distributed to the owners. A simplified bridge starts with enterprise value, subtracts funded debt and debt-like obligations, adjusts for working capital against a negotiated target, and then accounts for transaction expenses and any other specified items. The remainder is equity value available for allocation under the deal documents. Each term can materially change proceeds, so partners can compare the actual proceeds bridge with the headline multiple.

The multiple is meaningful only when the earnings measure is comparable. Buyers may use adjusted earnings before interest, taxes, depreciation plus amortization, often called adjusted EBITDA. Reconcile adjustments one by one. A buyer may accept a one-time recruiting fee or unusual legal cost as an add-back, while rejecting ongoing owner compensation, recurring locum coverage, or a management role that must be replaced after closing. For an OB-GYN practice, clarify how the analysis treats physician compensation, call coverage, hospital stipends, APP compensation, billing lag, and any costs paid through a related entity. A high multiple on a disputed earnings base may yield less than a lower multiple on a defensible base.

Separate cash at closing from rollover equity, seller notes and escrow, plus contingent consideration. Rollover means the owners reinvest part of their proceeds into the buyer’s company. It can create additional value, but it is illiquid. Its outcome depends on business performance and borrowing. Dilution and the terms of a future sale also affect value. A seller note is a loan from the sellers to the buyer; it carries repayment risk and depends on its priority and covenants; maturity also matters. Escrow or a holdback reserves cash for specified post-closing claims. An earnout pays only if defined performance targets are met. Each component has a different risk profile and should be shown separately in a sources-and-uses schedule and a per-partner distribution estimate.

Tax structure, ownership percentages, partner-specific basis, and allocation of proceeds can also change what each owner receives after tax. Different partners may have different preferences: one may prioritize liquidity for retirement while another wants to remain and share in future growth. Ask advisers to model the same transaction economics for each partner, including expected timing and tax treatment, without assuming that a common ownership percentage means a common net outcome. The comparison should include both value at closing and a reasonable range of value for retained or contingent interests.

What each buyer may contribute after closing

Strategic buyers can offer existing infrastructure, such as revenue cycle operations, payer contracting expertise, recruiting resources, compliance staff, information systems, purchasing scale, or management experience across several locations. Integration may reduce duplicated functions and support opening an office or adding clinicians. A strategic owner might coordinate services across markets or stabilize administrative functions that physician partners manage themselves.

Those benefits depend on concrete resources, not promises in a presentation. Determine which systems will replace existing systems, who pays for conversion, how long dual systems will operate, and what happens to outstanding claims during migration. Ask how the buyer will handle local payer relationships, hospital privileges, call coverage and referrals, plus vendor contracts. A strategic buyer may have policies that apply across its organization, limiting local exceptions. Map integration onto a 12 to 24 month operating plan with a named owner for each milestone. Budget conversion costs and track disruption to claims and clinic operations.

A sponsor may bring investment for recruiting, technology, new sites, acquisitions, or management depth, while allowing the platform to expand beyond a single market. It may introduce a structured budgeting process and help a physician group shift routine administrative work to professional managers. If the sponsor is building a regional women’s health platform, an existing practice can become a base for growth, and partners who roll over equity may participate in value created across more than one office or group.

Ask for the investment plan in operational terms. How much capital is budgeted for the practice, what approvals are required, and what must be funded from operating cash or new debt? Who decides whether to open a location, recruit a physician, or change an administrative vendor? What integration work has the sponsor completed in comparable practices? Which leaders will be accountable for the plan? A general commitment to growth is not a spending authorization. The owners should understand how capital decisions will be made and whether the practice’s cash needs compete with debt service or other platform priorities.

Governance and employment, with local control addressed directly

The sale agreement may transfer ownership, while employment agreements and governance documents define the partners’ continuing roles. Review them as a package. Identify who controls hiring and compensation, budgets, new services, office closures, physician schedules, call arrangements, and major capital expenses. Clinical judgment remains with appropriately licensed clinicians, but that principle does not answer who sets staffing levels, administrative policies, operating hours, or the financial parameters within which the practice functions. Owners need clarity about the line between clinical authority and business authority.

Strategic buyers may fold the group into an established reporting structure with regional or corporate leaders. This can make decisions faster when responsibilities are clear, but it can also reduce local discretion. Sponsor-backed platforms often establish a board or management committee and reserve certain decisions for investors or the platform parent. Ask which decisions require approval, how often the board meets, what information partners receive, and whether physician representatives have voting rights. A title such as medical director or regional president does not itself confer authority. The governing documents, budget process, and employment terms determine the practical role.

Employment agreements deserve close attention. Examine base compensation, productivity formulas, quality or administrative incentives, benefits, termination rights, notice periods, restrictive covenants where enforceable, and duties outside regular clinical work. Clarify how compensation changes if the practice adds clinicians, loses a hospital contract, or changes its call structure. For a partner who expects to reduce clinical time, establish how that affects compensation and any equity vesting. If a departing owner must sell or forfeit rollover equity, identify the valuation method and timing. Terms that seem secondary at signing may determine whether an owner can leave on acceptable terms later.

The sale may also involve a management services agreement, real estate lease, or professional services structure. Review fees, service levels, term, termination rights, ownership of records and systems, and any pass-through expenses. If the practice’s real estate is owned by partners, compare a sale of the property with a lease to the buyer. Confirm how rent is set and escalated; confirm how each change is treated in adjusted earnings. For any arrangement involving a separate professional entity, have qualified counsel assess the entity structure and applicable requirements. The commercial documents should fit together so that a promise in a term sheet is not contradicted by a long-term services contract.

Diligence and closing risk in an OB-GYN practice

Buyers examine revenue quality and dependence on key physicians. Their diligence also covers staffing and compliance, contract rights, and whether operations can continue after closing. OB-GYN practices often have multiple revenue streams and operational relationships: office visits, procedures, imaging or other ancillary services, hospital-related arrangements, call coverage, and employed or contracted clinicians. The buyer will want to understand how each stream is documented, who performs the work, what costs support it, and whether it can continue after a change in ownership. Reconcile the records behind any variation in revenue or expense. Broad assurances will not answer a buyer’s diligence question.

Prepare a consistent view of collections, charges, adjustments, accounts receivable aging, payer mix, denials, provider productivity and compensation, along with staffing. Tie reports to the general ledger and explain timing differences, including claims runout. Identify contracts requiring consent or notice upon a sale, such as payer agreements, leases, equipment arrangements, and hospital or call coverage agreements. List key-person responsibilities absent from job descriptions, including partner oversight of billing, recruiting, quality processes, and hospital relationships. This helps a buyer assess transition risk and sellers spot operational dependencies before price reductions.

Strategic buyers may focus on compatibility with their contracts and systems, plus the service footprint. They may require more detailed review of overlapping locations, existing referral or coverage arrangements, and the cost of integration. A sponsor may focus closely on normalized earnings, the depth of the management team, financial controls, and the ability to support future acquisitions. Both will scrutinize the quality of records and legal structure. Neither category eliminates diligence. A buyer that already knows the market can still discover problems that alter the deal, and a sponsor may place conditions on financing or investment approval.

Compare the path to closing as carefully as the price. Identify exclusivity duration, diligence deadlines, financing conditions, regulatory or third-party consents, partner approval thresholds, and termination rights. Ask who bears costs if a required consent is delayed or denied. Consider the buyer’s financing certainty and equity capitalization, including whether the purchase depends on lender approval or a further investment committee decision. A strategic organization may have internal approval processes; a sponsor may need debt financing and fund approval. Request a clear process calendar and named decision makers, then track open issues in a single list.

Illustrative worked comparison

Assume, for illustration only, that a four-physician practice reports $2.0 million in earnings before interest, taxes, depreciation plus amortization. After review, the parties agree that $1.8 million is a supportable adjusted EBITDA figure because $200,000 of proposed add-backs represent recurring coverage and administrative costs. A strategic buyer offers 7.0 times adjusted EBITDA, or $12.6 million in enterprise value. A sponsor-backed platform offers 7.4 times, or $13.32 million. On the headline figures, the sponsor offer appears higher by $720,000.

Now compare the terms. The strategic buyer proposes $11.8 million of cash at closing after a $500,000 escrow and an assumed $300,000 net debt and working capital adjustment. It includes no rollover and offers employment contracts with defined compensation and a two-year transition role for the managing partner. The sponsor proposes $8.0 million in cash at closing, $3.6 million of rollover equity, a $1.0 million seller note, and $720,000 subject to an earnout based on platform EBITDA over two years. It also proposes a $500,000 escrow and the same illustrative net adjustment. The stated components total $13.32 million, but only part is immediate cash.

Suppose the partners estimate that the sponsor’s rollover could be worth between $2.0 million and $5.0 million at a future sale, depending on growth and debt levels. Dilution and the terms of a future exit also affect the result. The seller note may be repaid as scheduled, but it remains exposed to the buyer’s credit. The earnout may pay nothing if acquisitions, accounting allocations, or operating results miss its threshold. Under those assumptions, the sponsor could deliver less or substantially more than the strategic buyer, while requiring owners to retain more risk and remain involved. The strategic offer gives more liquidity and clearer economics, but may offer less participation in future platform growth.

This example is illustrative, not a valuation benchmark. It shows why partners should calculate at least three columns: cash proceeds at closing, contractual payments that are not contingent on performance, and contingent or retained value under a downside case, a central case, and an upside case cases. Apply each partner’s ownership and distribution waterfall, then estimate taxes and transaction costs with advisers. Also compare expected work obligations, decision rights, and time required to receive later payments. A simple spreadsheet can show how a lower headline offer might produce more reliable near-term proceeds, or how a higher offer may compensate owners for genuine retained risk.

Common mistakes when comparing bids

One common mistake is treating the buyer label as a prediction of culture or autonomy. A strategic group may preserve the acquired practice’s identity, while a sponsor-backed platform may centralize administrative choices. The reverse is also possible. Test governance documents, service commitments, integration plans, and leader references. Ask each bidder what decisions partners will make after closing and obtain material commitments in writing.

Another mistake is comparing different earnings definitions or accepting a multiple without checking the underlying schedule. If one bid uses a higher earnings figure based on aggressive add-backs, its apparent premium may disappear under a consistent calculation. Ask bidders to price the same adjusted EBITDA bridge and identify any remaining disputed items. Include replacement costs for owner duties that will continue after the transaction. Do not count the same expense as an add-back and also assume that the buyer will absorb it without cost.

Owners can also overvalue rollover equity by applying the buyer’s projected growth multiple to the retained stake without accounting for debt, dilution, future capital needs, fees, or preferences. Rollover shares may rank behind preferred capital or be subject to transfer restrictions. Request the capitalization table, security terms, distribution waterfall, information rights, and examples of how additional acquisitions affect ownership. Understand whether a later sale is controlled by the sponsor and what happens if the sponsor extends its holding period.

Finally, partners sometimes negotiate the price before agreeing how they will make a decision. Set partner priorities, approval thresholds, and a process for handling conflicts before entering exclusivity. One partner’s desired retirement date can differ from another’s interest in staying for growth. A bid should be evaluated for every owner, not just the managing partner. Keep a written comparison of economics, control, employment, closing conditions, and post-close obligations, and revisit it when the buyer changes material terms.

Action checklist

Ask each partner to rank liquidity and control, then growth and workload. Record acceptable timing in a separate note.
Normalize earnings using one documented schedule and a supportable treatment of recurring costs.
Bridge enterprise value to cash at closing after debt and working capital. Show the escrow and seller note, then list the earnout and rollover equity separately.
Map decision rights across ownership, employment, management services and leases, alongside governance terms documents.
Test each buyer’s operating plan, funding commitments, integration costs, and accountable leaders.
Confirm diligence scope, consent requirements, financing conditions and exclusivity; also review the expected closing process.
Model partner-level net proceeds and retained value under a downside case, a central case, and an upside case assumptions with qualified advisers.
Record the reasons for selecting a buyer and the obligations each owner accepts after closing.

Questions about your own practice? Contact richard@doctorsinvestorclub.com.